Jeffrey S A Stringer

Summary

Affiliation: Centre for Infectious Disease Research in Zambia
Country: Zambia

Publications

  1. pmc Effectiveness of generic and proprietary first-line anti-retroviral regimens in a primary health care setting in Lusaka, Zambia: a cohort study
    Jeffrey S A Stringer
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    Int J Epidemiol 41:448-59. 2012
  2. pmc Effectiveness of a city-wide program to prevent mother-to-child HIV transmission in Lusaka, Zambia
    Jeffrey Sa Stringer
    Schools of Medicine and Public Health, University of Alabama at Birmingham, USA
    AIDS 19:1309-15. 2005
  3. pmc Effectiveness of non-nucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in women previously exposed to a single intrapartum dose of nevirapine: a multi-country, prospective cohort study
    Jeffrey S A Stringer
    University of Alabama at Birmingham Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    PLoS Med 7:e1000233. 2010
  4. doi Extended nevirapine prophylaxis to prevent HIV transmission
    Jeffrey S A Stringer
    University of Alabama at Birmingham, Centre for Infectious Disease Research in Zambia CIDRZ, Lusaka, Zambia
    Lancet 372:267-9. 2008
  5. pmc Measuring coverage in MNCH: population HIV-free survival among children under two years of age in four African countries
    Jeffrey S A Stringer
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    PLoS Med 10:e1001424. 2013
  6. pmc Intrapartum tenofovir and emtricitabine reduces low-concentration drug resistance selected by single-dose nevirapine for perinatal HIV prevention
    Benjamin H Chi
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    AIDS Res Hum Retroviruses 25:1099-106. 2009
  7. doi Addition of single-dose tenofovir and emtricitabine to intrapartum nevirapine to reduce perinatal HIV transmission
    Benjamin H Chi
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    J Acquir Immune Defic Syndr 48:220-3. 2008
  8. pmc Early clinical and programmatic outcomes with tenofovir-based antiretroviral therapy in Zambia
    Benjamin H Chi
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    J Acquir Immune Defic Syndr 54:63-70. 2010
  9. pmc Early clinical and immune response to NNRTI-based antiretroviral therapy among women with prior exposure to single-dose nevirapine
    Benjamin H Chi
    Centre for Infectious Disease Research in Zambia, Zambia
    AIDS 21:957-64. 2007
  10. pmc Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia
    Benjamin H Chi
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    Int J Epidemiol 38:746-56. 2009

Detail Information

Publications74

  1. pmc Effectiveness of generic and proprietary first-line anti-retroviral regimens in a primary health care setting in Lusaka, Zambia: a cohort study
    Jeffrey S A Stringer
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    Int J Epidemiol 41:448-59. 2012
    ..Although generic anti-retroviral drugs are in common use throughout the developing world, studies comparing their clinical effectiveness with that of proprietary formulations are lacking...
  2. pmc Effectiveness of a city-wide program to prevent mother-to-child HIV transmission in Lusaka, Zambia
    Jeffrey Sa Stringer
    Schools of Medicine and Public Health, University of Alabama at Birmingham, USA
    AIDS 19:1309-15. 2005
    ..To determine the population effectiveness of a city-wide perinatal HIV prevention program...
  3. pmc Effectiveness of non-nucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in women previously exposed to a single intrapartum dose of nevirapine: a multi-country, prospective cohort study
    Jeffrey S A Stringer
    University of Alabama at Birmingham Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    PLoS Med 7:e1000233. 2010
    ....
  4. doi Extended nevirapine prophylaxis to prevent HIV transmission
    Jeffrey S A Stringer
    University of Alabama at Birmingham, Centre for Infectious Disease Research in Zambia CIDRZ, Lusaka, Zambia
    Lancet 372:267-9. 2008
  5. pmc Measuring coverage in MNCH: population HIV-free survival among children under two years of age in four African countries
    Jeffrey S A Stringer
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    PLoS Med 10:e1001424. 2013
    ..We measured PMTCT service coverage, regimen use, and HIV-free survival among children ≤24 mo of age in Cameroon, Côte D'Ivoire, South Africa, and Zambia...
  6. pmc Intrapartum tenofovir and emtricitabine reduces low-concentration drug resistance selected by single-dose nevirapine for perinatal HIV prevention
    Benjamin H Chi
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    AIDS Res Hum Retroviruses 25:1099-106. 2009
    ..The ability of single-dose TDF/FTC to protect against peripartum NVP-induced NNRTI resistance extends to minority populations. This efficacy is achieved without significant selection of TDF- or FTC-resistant viruses...
  7. doi Addition of single-dose tenofovir and emtricitabine to intrapartum nevirapine to reduce perinatal HIV transmission
    Benjamin H Chi
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    J Acquir Immune Defic Syndr 48:220-3. 2008
    ..To determine the impact of adjuvant single-dose peripartum tenofovir/emtricitabine (TDF/FTC) on intrapartum/early postpartum HIV transmission...
  8. pmc Early clinical and programmatic outcomes with tenofovir-based antiretroviral therapy in Zambia
    Benjamin H Chi
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    J Acquir Immune Defic Syndr 54:63-70. 2010
    ..In July 2007, amid some controversy over cost, Zambia was the first African country to introduce tenofovir (TDF) as a component of first-line antiretroviral therapy (ART) on a wide scale...
  9. pmc Early clinical and immune response to NNRTI-based antiretroviral therapy among women with prior exposure to single-dose nevirapine
    Benjamin H Chi
    Centre for Infectious Disease Research in Zambia, Zambia
    AIDS 21:957-64. 2007
    ....
  10. pmc Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia
    Benjamin H Chi
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    Int J Epidemiol 38:746-56. 2009
    ..In resource-constrained settings, however, there are few validated measures. We examined the correlation between clinical outcomes and the medication possession ratio (MPR), a pharmacy-based measure of adherence...
  11. pmc Peripartum nevirapine exposure and subsequent clinical outcomes among HIV-infected women receiving antiretroviral therapy for at least 12 months
    Namwinga Chintu
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    Trop Med Int Health 15:842-7. 2010
    ..We examined the longer-term clinical outcomes in a programmatic setting...
  12. pmc Advancing cervical cancer prevention initiatives in resource-constrained settings: insights from the Cervical Cancer Prevention Program in Zambia
    Mulindi H Mwanahamuntu
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    PLoS Med 8:e1001032. 2011
    ....
  13. pmc An empirical approach to defining loss to follow-up among patients enrolled in antiretroviral treatment programs
    Benjamin H Chi
    Centre for Infectious Disease Research in Zambia, Box 34681, 1275 Lubuto Road, Lusaka, Zambia
    Am J Epidemiol 171:924-31. 2010
    ..This analysis suggests that > or =60 days since the last appointment is a reasonable definition of LTFU. Standardization to empirically derived definitions of LTFU will permit more reliable comparisons within and across programs...
  14. ncbi Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial
    Benjamin H Chi
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    Lancet 370:1698-705. 2007
    ..We aimed to investigate whether this complication would be reduced with a single peripartum intervention of tenofovir and emtricitabine...
  15. doi HIV disease progression by hormonal contraceptive method: secondary analysis of a randomized trial
    Elizabeth M Stringer
    Centre for Infectious Disease Research, Lusaka, Zambia
    AIDS 23:1377-82. 2009
    ..We hypothesized that women using depomedroxyprogesterone acetate (DMPA) contraception would have faster HIV disease progression than women using oral contraceptive pills (OCPs) and nonhormonal methods...
  16. pmc Six-month hemoglobin concentration and its association with subsequent mortality among adults on antiretroviral therapy in Lusaka, Zambia
    Mark J Giganti
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    J Acquir Immune Defic Syndr 61:120-3. 2012
    ..5; 95% confidence interval: 3.3 to 6.3). Future work should look to identify causes of anemia in settings such as ours and evaluate strategies for more timely diagnosis and treatment...
  17. pmc Do targeted HIV programs improve overall care for pregnant women?: Antenatal syphilis management in Zambia before and after implementation of prevention of mother-to-child HIV transmission programs
    Dara Potter
    Schools of Public Health and Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
    J Acquir Immune Defic Syndr 47:79-85. 2008
    ..The implementation of disease-specific research or service programs may have an ancillary beneficial or harmful impact on routine clinical services...
  18. doi Coverage of nevirapine-based services to prevent mother-to-child HIV transmission in 4 African countries
    Elizabeth M Stringer
    Centre for Infectious Disease Research in Zambia, Plot 1275 Lubutu Rd, PO Box 34681, Lusaka, Zambia
    JAMA 304:293-302. 2010
    ..Few studies have objectively evaluated the coverage of services to prevent transmission of human immunodeficiency virus (HIV) from mother to child...
  19. pmc Universal nevirapine upon presentation in labor to prevent mother-to-child HIV transmission in high prevalence settings
    Jeffrey S A Stringer
    Schools of Medicine and Public Health, University of Alabama at Birmingham, Birmingham, Alabama, USA
    AIDS 18:939-43. 2004
    ..To assess the uptake of and adherence to nevirapine to prevent mother-to-child HIV transmission among women of unknown HIV serostatus presenting in labor. We also assessed preliminary efficacy of the approach...
  20. pmc Timing of the maternal drug dose and risk of perinatal HIV transmission in the setting of intrapartum and neonatal single-dose nevirapine
    Jeffrey S A Stringer
    Schools of Medicine and Public Health, University of Alabama at Birmingham, Birmingham, Alabama, USA
    AIDS 17:1659-65. 2003
    ..Single-dose intrapartum and neonatal nevirapine (NVP) reduces perinatal HIV transmission and is in increasingly common use throughout the developing world...
  21. pmc CD4+ response and subsequent risk of death among patients on antiretroviral therapy in Lusaka, Zambia
    Benjamin H Chi
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    J Acquir Immune Defic Syndr 52:125-31. 2009
    ..However, few have studied CD4+ response and its relationship to subsequent clinical outcomes in a programmatic setting...
  22. pmc Association between weight gain and clinical outcomes among malnourished adults initiating antiretroviral therapy in Lusaka, Zambia
    John R Koethe
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    J Acquir Immune Defic Syndr 53:507-13. 2010
    ..To describe the association between 6-month weight gain on antiretroviral therapy (ART) and subsequent clinical outcomes...
  23. pmc A pilot study of food supplementation to improve adherence to antiretroviral therapy among food-insecure adults in Lusaka, Zambia
    Ronald A Cantrell
    Centre for Infectious Disease Research in Zambia, Plot 1275 Lubutu Road, Lusaka, Zambia
    J Acquir Immune Defic Syndr 49:190-5. 2008
    ..The provision of food supplementation to food-insecure patients initiating antiretroviral therapy (ART) may improve adherence to medications...
  24. ncbi Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes
    Jeffrey S A Stringer
    Schools of Medicine and Public Health, University of Alabama at Birmingham, Birmingham, USA
    JAMA 296:782-93. 2006
    ..The Zambian Ministry of Health has scaled-up human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) care and treatment services at primary care clinics in Lusaka, using predominately nonphysician clinicians...
  25. pmc Comparison of two strategies for administering nevirapine to prevent perinatal HIV transmission in high-prevalence, resource-poor settings
    Jeffrey S A Stringer
    Department of Obstetrics and Gynecology, Schools of Medicine and Public Health, University of Alabama at Birmingham, Alabama, USA
    J Acquir Immune Defic Syndr 32:506-13. 2003
    ....
  26. pmc Predictors of CD4 eligibility for antiretroviral therapy initiation among HIV-infected pregnant women in Lusaka, Zambia
    Katherine C Liu
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    J Acquir Immune Defic Syndr 57:e101-5. 2011
    ..In resource-limited settings, CD4 testing is a barrier to antiretroviral therapy initiation in pregnancy...
  27. pmc Nonvirologic algorithms for predicting HIV infection among HIV-exposed infants younger than 12 weeks of age
    Benjamin H Chi
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    Pediatr Infect Dis J 32:151-6. 2013
    ..Early initiation of antiretroviral therapy has been shown to reduce mortality among perinatally HIV-infected infants, but availability of virologic testing remains limited in many settings...
  28. doi Causes of morbidity among HIV-infected children on antiretroviral therapy in primary care facilities in Lusaka, Zambia
    Mwangelwa Mubiana-Mbewe
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    Trop Med Int Health 14:1190-8. 2009
    ..To describe the pattern of incident illness in children after initiation of antiretroviral therapy (ART) in a large public health sector programme in Lusaka, Zambia...
  29. pmc Personal risk perception, HIV knowledge and risk avoidance behavior, and their relationships to actual HIV serostatus in an urban African obstetric population
    Elizabeth M Stringer
    Schools of Medicine and Public Health, University of Alabama at Birmingham, Birmingham, AL, USA
    J Acquir Immune Defic Syndr 35:60-6. 2004
    ..Before significant inroads can be made in decreasing the incidence of HIV infection among pregnant women, population-based strategies that involve men must be implemented...
  30. ncbi Field performance of a thin-layer chromatography assay for detection of nevirapine in umbilical cord blood
    Benjamin H Chi
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    HIV Clin Trials 7:263-9. 2006
    ..At present, the only validated method is high-performance liquid chromatography (HPLC), a technique poorly suited for most resource-constrained settings...
  31. pmc Comparative outcomes of tenofovir-based and zidovudine-based antiretroviral therapy regimens in Lusaka, Zambia
    Benjamin H Chi
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    J Acquir Immune Defic Syndr 58:475-81. 2011
    ..Although tenofovir (TDF) is a common component of antiretroviral therapy (ART), recent evidence suggests inferior outcomes when it is combined with nevirapine (NVP)...
  32. ncbi Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia
    Carolyn Bolton-Moore
    Centre for Infectious Disease Research in Zambia, Lusaka
    JAMA 298:1888-99. 2007
    ....
  33. pmc Implementation of the Zambia electronic perinatal record system for comprehensive prenatal and delivery care
    Benjamin H Chi
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    Int J Gynaecol Obstet 113:131-6. 2011
    ..To characterize prenatal and delivery care in an urban African setting...
  34. pmc A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus
    Elizabeth M Stringer
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    Am J Obstet Gynecol 197:144.e1-8. 2007
    ..The purpose of this study was to determine whether the intrauterine contraceptive device (IUD) is effective and safe among women who are infected with the human immunodeficiency virus (HIV)...
  35. pmc Methods and baseline results of a repeated cross-sectional survey to assess the public health impact of antiretroviral therapy in Lusaka, Zambia
    Mark J Giganti
    Centre for Infectious Disease Research in Zambia, Box 34681, Plot 1275, Lubuto Road, Lusaka, Zambia
    Am J Trop Med Hyg 82:971-7. 2010
    ..These findings will serve as a reliable reference in the future analysis of the population-level impact of this HIV treatment and care program in Zambia...
  36. pmc Influence of body mass index on pregnancy outcomes among HIV-infected and HIV-uninfected Zambian women
    Yolan Banda
    School of Medicine, University of Zambia, Lusaka, Zambia
    Trop Med Int Health 12:856-61. 2007
    ..To determine the influence of body mass index (BMI) on pregnancy outcomes of HIV-infected and HIV-uninfected Zambian women and to assess the possible role of BMI on mother-to-child transmission rate of HIV...
  37. ncbi Nevirapine to prevent mother-to-child transmission of HIV-1 among women of unknown serostatus
    Jeffrey S A Stringer
    Schools of Medicine and Public Health, University of Alabama at Birmingham, Birmingham, Alabama, USA
    Lancet 362:1850-3. 2003
  38. pmc A cluster randomized trial of routine HIV-1 viral load monitoring in Zambia: study design, implementation, and baseline cohort characteristics
    John R Koethe
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    PLoS ONE 5:e9680. 2010
    ....
  39. ncbi Use of traditional medicine among pregnant women in Lusaka, Zambia
    Yolan Banda
    University of Zambia School of Medicine, Lusaka, Zambia
    J Altern Complement Med 13:123-7. 2007
    ..We studied the prevalence of and predictors for traditional medicine use among pregnant women seeking care in the Lusaka, Zambia public health system...
  40. ncbi Cost and enrollment implications of targeting different source population for an HIV treatment program
    Benjamin H Chi
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    J Acquir Immune Defic Syndr 40:350-5. 2005
    ..Rapid scale-up of antiretroviral therapy (ART) is a worldwide priority, and ambitious targets for numbers on ART have been set. Antenatal clinics (ANCs) and tuberculosis (TB) clinics have been targeted as entry points into HIV care...
  41. pmc Effect of nevirapine toxicity on choice of perinatal HIV prevention strategies
    Jeffrey S A Stringer
    Center for Research in Women s Health, University of Alabama at Birmingham, Birmingham, AL, USA
    Am J Public Health 92:365-6. 2002
    ..This study evaluated the validity of concerns about the toxicity of nevirapine (NVP) that have delayed its implementation as a perinatal HIV prevention strategy...
  42. pmc Causes of stillbirth, neonatal death and early childhood death in rural Zambia by verbal autopsy assessments
    Eleanor Turnbull
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    Trop Med Int Health 16:894-901. 2011
    ..To describe specific causes of the high rates of stillbirth, neonatal death and early child childhood death in Zambia...
  43. pmc Serum phosphate predicts early mortality in adults starting antiretroviral therapy in Lusaka, Zambia: a prospective cohort study
    Douglas C Heimburger
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    PLoS ONE 5:e10687. 2010
    ..We assessed the association of serum phosphate with early mortality among HIV-infected adults with severe malnutrition and/or advanced immunosuppression...
  44. pmc Predictors and pregnancy outcomes associated with a newborn birth weight of 4000 g or more in Lusaka, Zambia
    Katherine C Liu
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    Int J Gynaecol Obstet 122:150-5. 2013
    ..To identify predictors and outcomes associated with a birth weight of 4000g or more in Lusaka, Zambia...
  45. doi Progress, challenges, and new opportunities for the prevention of mother-to-child transmission of HIV under the US President's Emergency Plan for AIDS Relief
    Benjamin H Chi
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    J Acquir Immune Defic Syndr 60:S78-87. 2012
    ..PEPFAR must also carefully integrate PMTCT into the broader combination prevention agenda for HIV, so that real progress can be made toward an "AIDS-free generation" worldwide...
  46. pmc Monitoring effectiveness of programmes to prevent mother-to-child HIV transmission in lower-income countries
    Elizabeth M Stringer
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    Bull World Health Organ 86:57-62. 2008
    ..Finally, we propose a novel community survey-based approach that could be implemented widely throughout the developing world with minor modifications to ongoing Demographic and Health Surveys...
  47. ncbi Complete blood cell count as a surrogate CD4 cell marker for HIV monitoring in resource-limited settings
    Ray Y Chen
    Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
    J Acquir Immune Defic Syndr 44:525-30. 2007
    ..We developed a more effective method based on a decision tree algorithm to classify subjects...
  48. pmc Antiretroviral drug regimens to prevent mother-to-child transmission of HIV: a review of scientific, program, and policy advances for sub-Saharan Africa
    Benjamin H Chi
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    Curr HIV/AIDS Rep 10:124-33. 2013
    ..In this review, we take stock of recent advances across each of these areas, highlighting the challenges--and opportunities--of improving health services for HIV-infected mothers and their children across the region...
  49. pmc Simple adherence assessments to predict virologic failure among HIV-infected adults with discordant immunologic and clinical responses to antiretroviral therapy
    Jason D Goldman
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    AIDS Res Hum Retroviruses 24:1031-5. 2008
    ..Among patients with suspected treatment failure, a lower MPR was associated with higher rates of detectable viremia. However, the suboptimal sensitivity and specificity of MPR limit its utility as a sole predictor of virologic failure...
  50. pmc Macronutrient supplementation for malnourished HIV-infected adults: a review of the evidence in resource-adequate and resource-constrained settings
    John R Koethe
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    Clin Infect Dis 49:787-98. 2009
    ....
  51. pmc Short communication: Late refills during the first year of antiretroviral therapy predict mortality and program failure among HIV-infected adults in urban Zambia
    Michael J Vinikoor
    1 Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    AIDS Res Hum Retroviruses 30:74-7. 2014
    ..Monitoring late refills during the initial period of ART may help resource- and time-constrained clinics identify patients at risk for program failure...
  52. doi Breastfeeding in HIV-positive women: What can be recommended?
    Mackenzie Slater
    University of Alabama at Birmingham, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    Paediatr Drugs 12:1-9. 2010
    ....
  53. ncbi HIVCorps: using volunteers to rapidly expand HIV health services across Zambia
    Benjamin H Chi
    Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
    Am J Trop Med Hyg 74:918-21. 2006
    ..Formal volunteer programs like HIVCorps should be developed alongside initiatives focused on deploying more specialized, experienced healthcare workers aboard...
  54. pmc Use of task-shifting to rapidly scale-up HIV treatment services: experiences from Lusaka, Zambia
    Mary B Morris
    Centre for Infectious Disease Research in Zambia Lusaka, Zambia
    BMC Health Serv Res 9:5. 2009
    ..While this approach has been successful, long-term solutions to the human resource crisis are also urgently needed to expand the number of providers and to slow staff migration out of the region...
  55. ncbi Perceptions toward HIV, HIV screening, and the use of antiretroviral medications: a survey of maternity-based health care providers in Zambia
    Benjamin H Chi
    Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas, USA
    Int J STD AIDS 15:685-90. 2004
    ..Among those never prescribing ART, most cited a lack of availability (83%). Our results highlight the need for further provider education, critical appraisal of the current system for HIV testing, and widespread distribution of ART...
  56. doi A controlled trial of three methods for neonatal circumcision in Lusaka, Zambia
    Kasonde Bowa
    Department of Surgery, Copperbelt University School of Medicine, Ndola, Zambia
    J Acquir Immune Defic Syndr 62:e1-6. 2013
    ..Neonatal male circumcision (NMC) is not routinely practiced in Zambia, but it is a promising long-term HIV prevention strategy. We studied the feasibility and safety of three different NMC methods...
  57. ncbi Two decades of the safe motherhood initiative: time for another wooden spoon award?
    Alan T N Tita
    Center for Women s Reproductive Health and Maternal Fetal Medicine Division, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama 35233, USA
    Obstet Gynecol 110:972-6. 2007
    ....
  58. pmc Are treatments for cervical precancerous lesions in less-developed countries safe enough to promote scaling-up of cervical screening programs? A systematic review
    Eric Chamot
    Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA
    BMC Womens Health 10:11. 2010
    ....
  59. pmc eC3--a modern telecommunications matrix for cervical cancer prevention in Zambia
    Groesbeck P Parham
    Center for Infectious Disease Research in Zambia, Lusaka, Zambia
    J Low Genit Tract Dis 14:167-73. 2010
    ..Low physician density, undercapacitated laboratory infrastructures, and limited resources are major limitations to the development and implementation of widely accessible cervical cancer prevention programs in sub-Saharan Africa...
  60. ncbi Acute and chronic chorioamnionitis and the risk of perinatal human immunodeficiency virus-1 transmission
    Benjamin H Chi
    School of Medicine, University of Alabama, Birmingham, AL 35294 0024, USA
    Am J Obstet Gynecol 194:174-81. 2006
    ..This study was undertaken to examine the prevalence of acute and chronic chorioamnionitis among women infected with human immunodeficiency virus-1 (HIV-1) and to determine the relative contribution of each to perinatal HIV-1 transmission...
  61. pmc Management of cryotherapy-ineligible women in a "screen-and-treat" cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field
    Krista S Pfaendler
    University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
    Gynecol Oncol 110:402-7. 2008
    ..We demonstrate the feasibility of implementing a referral and management system for cryotherapy-ineligible women in a "screen-and-treat" cervical cancer prevention program targeting HIV-infected women in Zambia...
  62. ncbi Monitoring nevirapine-based programmes for prevention of mother-to-child transmission of HIV-1
    Jeffrey S A Stringer
    Lancet 362:667. 2003
  63. pmc Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, Zambia
    Lloyd B Mulenga
    Centre for Infectious Disease Research, Zambia
    AIDS 22:1821-7. 2008
    ..To examine the association between baseline renal insufficiency and mortality among adults initiating antiretroviral therapy (ART) in an urban African setting...
  64. ncbi Individual-level predictors for HIV testing among antenatal attendees in Lusaka, Zambia
    Sara Thierman
    University of California School of Medicine, San Francisco, California, USA
    Am J Med Sci 332:13-7. 2006
    ..Because individual-level characteristics were only weakly predictive of HIV testing, future work should concentrate on community-level factors...
  65. ncbi Effects of concentration and temperature on the stability of nevirapine in whole blood and serum
    Chantelle J Bennetto
    The University of Alabama at Birmingham, School of Medicine, Division of Clinical Pharmacology, 1530 3rd Ave South, VH 116, Birmingham, AL 35294 0019, USA
    Clin Chem 50:209-11. 2004
  66. ncbi Detection of nevirapine in plasma using thin-layer chromatography
    Jeffrey G Dubuisson
    Division of Clinical Pharmacology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham School of Medicine, USA
    J Acquir Immune Defic Syndr 35:155-7. 2004
    ..This report describes a fast, inexpensive thin-layer chromatography (TLC) method to detect the presence of NVP in human plasma...
  67. ncbi Use of single-dose nevirapine for the prevention of mother-to-child transmission of HIV-1: does development of resistance matter?
    Michelle S McConnell
    Thailand US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand
    Am J Obstet Gynecol 197:S56-63. 2007
    ..Further research in the optimization of perinatal prevention regimens is needed...
  68. ncbi Rapid testing strategies for HIV-1 serodiagnosis in high-prevalence African settings
    Richard J Wright
    Tufts University School of Medicine Wright, Boston, Massachusetts, USA
    Am J Prev Med 27:42-8. 2004
    ..While recent commitment of resources from international donors is heartening, rational use of these resources for AIDS prevention and care will require a major scaling up of HIV diagnostic services in affected countries...
  69. ncbi Prevention of pediatric human immunodeficiency virus
    Catherine M Wilfert
    Elizabeth Glaser Pediatric AIDS Foundation, Duke University School of Medicine, 1917 Wildcat Creek Road, Chapel Hill, NC 27516, USA
    Semin Pediatr Infect Dis 15:190-8. 2004
  70. ncbi Potential cost-effectiveness of maternal and infant antiretroviral interventions to prevent mother-to-child transmission during breast-feeding
    Courtney C Maclean
    Duke University School of Medicine, Durham, NC, USA
    J Acquir Immune Defic Syndr 38:570-7. 2005
    ..One-third of maternal-to-child HIV transmission occurs during breast-feeding (BF). Several trials are currently evaluating the efficacy of postpartum antiretrovirals to reduce BF transmission...
  71. ncbi Expanded services for the prevention of mother-to-child HIV transmission: field acceptability of a pilot program in Lusaka, Zambia
    Benjamin H Chi
    J Acquir Immune Defic Syndr 45:125-7. 2007
  72. ncbi Employment of off-duty staff: a strategy to meet the human resource needs for a large PMTCT program in Zambia
    Benjamin H Chi
    J Acquir Immune Defic Syndr 40:381-2. 2005
  73. pmc Integrating cervical cancer prevention in HIV/AIDS treatment and care programmes
    Mulindi H Mwanahamuntu
    Bull World Health Organ 86:D-E. 2008
  74. ncbi Cesarean delivery and risk of herpes simplex virus infection
    Dwight J Rouse
    JAMA 289:2208; author reply 2208-9. 2003